Exploration of Neuroimaging and Biochemical Prognostic Indicators for POCD
NCT ID: NCT02164669
Last Updated: 2014-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2013-05-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MD2, Cystatin C and DNA Methylation Tags as Serum Biomarkers for POCD.
NCT03610191
Incidence of Postoperative Cognitive Decline in Patients With Preexisting Cognitive Impairment
NCT07135336
Neuroimaging Combining Biomarkers for Identifying Long-term Cognitive Dysfunction and Delirium
NCT05594966
Screening of Susceptibility Genes in Postoperative Cognitive Dysfunction(POCD)
NCT02084030
Study of Postoperative Cognitive Decline in Aged Patients
NCT03765840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent selective CABG surgery
Exclusion Criteria
* History of taking sedative, antidepressants, or alcoholism
* MMSE score less than 23
* Visual or auditory disorders
* Educated less than 7 years
* Claustrophobia
* Can not be supine
* Can not tolerate iodinated contrast agents
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
wangqiang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
wangqiang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qiang Wang, MD, PhD
Role: STUDY_DIRECTOR
Xijing Hospital
Zijun Gao, Dr.
Role: PRINCIPAL_INVESTIGATOR
Xijing Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xijign Hospital
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20130225-8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.